Studies underway on cases of sudden cardiac arrest among youngsters after Covid: Govt

July 22, 2023
Posted by: OptimizeIAS Team
Category: DPN Topics

No Comments

Studies underway on cases of sudden cardiac arrest among youngsters after Covid: Govt

Subject :Schemes

Context:

Sudden deaths have been reported in some young people after COVID-19 but sufficient evidence is not available to confirm the cause.

Details:

The Indian Council of Medical Research is conducting three different studies to ascertain the facts regarding rising cases of cardiac arrest after the pandemic.
A multi-centric matched case control study on factors associated with sudden deaths among adults aged 18 to 45 in India is ongoing at around 40 hospitals/research centres.
Another multicentric hospital-based matched case control study is underway at around 30 COVID-19 clinical registry hospitals to determine the effect of the Covid vaccine on thrombotic events among the population aged 18 to 45 in 2022 in India.

National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD):

To address the health issues related to cardiovascular disease, the Centre’s Department of Health and Family Welfare provides technical and financial support to states and Union Territories under the National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD).
Cardiovascular disease is an integral part of NP-NCD.
The programme includes:
- Strengthening infrastructure,
- Human resource development,
- Health promotion,
- Population-based screening of the population in the 30-year and above age group under the Ayushman Bharat Health Wellness Centre,
- Early diagnosis, and
- Management and referral to an appropriate level of health care facility.
Under NP-NCD, 724 district non-communicable disease clinics, 210 district cardiac care units, 326 district day care centres and 6,110 community health centre non-communicable disease clinics have been set up.

Government’s effort to provide accessible and affordable health care:

To facilitate accessible and affordable health care and treatment under the Pradhan Mantri Jan Arogya Yojana (PMJAY), health insurance cover of Rs 5 lakh per family per year for secondary or tertiary care hospitalisation is provided to over 60 crore beneficiaries.
- The treatment packages are comprehensive, covering various treatment related aspects such as drugs and diagnostic services.
Under the umbrella scheme of the Rashtriya Arogya Nidhi, financial assistance is provided to families living below the threshold poverty line for treatment in government hospitals.
Besides, quality generic medicines are made available at affordable prices to all under the Pradhan Mantri Bhartiya Janaushadhi Pariyojana, in collaboration with the state governments.
Affordable medicines and reliable implants for treatment (AMRIT) pharmacy stores have been set up in some hospitals/institutions with an objective to make available cardiovascular drugs at a substantial discount, vis-à-vis the maximum retail price.

Health scheme	Description
National Programme for Prevention and Control of Non-Communicable Diseases (NP-NCD)	About: NP-NCD is being implemented under the National Health Mission (NHM) across the country. Aim: It was launched in 2010 with a focus on strengthening infrastructure, human resource development, health promotion, early diagnosis, management and referral. Management: Under NP-NCD, NCD Cells are being established at National, State and District levels for programme management, and NCD Clinics are being set up at District and Community Health Centres (CHC) levels, to provide services for early diagnosis, treatment and follow-up for common NCDs.
National Health Mission (NHM)	NHM was launched by the government of India in 2013 subsuming the National Rural Health Mission and the National Urban Health Mission. The main programmatic components include Health System Strengthening in rural and urban areas for – Reproductive-Maternal- Neonatal-Child and Adolescent Health (RMNCH+A), and Communicable and Non-Communicable Diseases. The NHM envisages achievement of universal access to equitable, affordable & quality health care services that are accountable and responsive to people’s needs. The National Health Mission seeks to ensure the achievement of the following indicators: Reduce Maternal Mortality Rate (MMR) to 1/1000 live births Reduce Infant Mortality rate (IMR) to 25/1000 live births Reduce Total Fertility Rate (TFR) to 2.1 Prevention and reduction of anaemia in women aged 15–49 years Prevent and reduce mortality & morbidity from communicable, non- communicable; injuries and emerging diseases Reduce household out-of-pocket expenditure on total health care expenditure Reduce annual incidence and mortality from Tuberculosis by half Reduce the prevalence of Leprosy to <1/10000 population and incidence to zero in all districts Annual Malaria Incidence to be <1/1000 Less than 1 per cent microfilaria prevalence in all districts Kala-azar Elimination by 2015, <1 case per 10000 population in all blocks
Rashtriya Arogya Nidhi	Rashtriya Arogya Nidhi is known as RAN is a National Illness Assistance Fund that was set up in 1997 on 13 January. It initially received a financial contribution of 5 crores from the Ministry of Health & Family Welfare. The main motive of RAN is to provide financial assistance to the patients who live below the poverty line and go through serious illness or life-threatening diseases related to a few departments at the government hospitals.
Pradhan Mantri Bhartiya Janaushadhi Pariyojana	PMBJP is a campaign launched by the Department of Pharmaceuticals in 2008 under the name Jan Aushadhi Campaign. The campaign was revamped as PMBJP in 2015-16. Bureau of Pharma PSUs of India (BPPI) is the implementation agency for PMBJP. The Bureau of Pharma Public Sector Undertakings (PSUs) of India works under the Ministry of Chemicals & Fertilisers. BPPI has also developed the Janaushadhi Sugam Application. A medicine is priced on the principle of maximum 50% of average price of the top three brands branded medicines. Thus, the prices of Jan Aushadhi Medicines are cheaper by at least 50% and in some cases, by 80% to 90% of the market price of the branded medicines.
Affordable medicines and reliable implants for treatment	Ministry : Ministry of Health and Family Welfare Aims to reduce the expenditure incurred by patients on treatment of cancer and heart diseases Program: To open AMRIT outlets which would sell medicines and equipment at affordable prices To open in all central government hospitals Its intended beneficiaries are patients suffering from cancer and heart diseases (non-communicable diseases). The project is implemented by government-owned HLL Lifecare Ltd (HLL) which is deputed to establish and run AMRIT chain of pharmacies across the country. These drugs and implants under the scheme will be sold based upon authentic prescriptions from doctors. At the AMRIT outlets, 202 cancer and 186 cardio-vascular drugs will be available at a reduced rate of 60 to 90% compared to market rates.